CardioGenomics
overview researchers projects data publications events links
What's New
Candidate Genes
How to Cite Us
FAQ's
Other PGA's
Contact Us
Sign In
View other projects: 1  2   3   4   5

Links to Methodology and Data:

Overview of Project 5:

We are comprehensively characterizing common genetic variation (linkage disequilibrium [LD] structure) in 52 candidate genes and identifying common missense variants in an additional 150 candidate genes identified by the mouse and human studies described in Projects 1-4, and determining which of these genotypes are associated with echocardiographic measures of left ventricular size and function among members of the Framingham Heart Study (FHS). DNA samples from the Framingham cohort are sent to the Broad Institute for genetic analysis.

The primary goals of Project 5 of the PGA are:

  1. To identify common missense single nucleotide polymorphisms (DNA sequence variants) of known and newly characterized candidate genes by using high-throughput resequencing technology.
  2. Characterize common genetic variation in a set of 50 highest priority candidate genes. We genotype SNPs from public and private databases as well as our own resequencing effort to create high-resolution linkage disequilibrium maps of SNPs.
  3. To select sets of tag SNPs (tSNPs) that efficiently capture common variation in 50 highest priority candidate genes.
  4. To genotype missense SNPs from (1) and tSNPs from (2) in 1811 participants of the Framingham Heart Study.
  5. To test the association of missense SNPs and tag SNPs with left ventricular mass, left ventricular and left atrial chamber size, aortic root size and related secondary measures (LV ejection fraction and fractional wall shortening) in a well characterized population-based cohort using a staged two-step analysis that includes both
    • Population-based case-control methods
    • Replication in an independent sample of related individuals using family-based association tests

Secondary goals include:

  1. To explore possible gene-environment interactions with age, sex, blood pressure, body mass index and other covariates.
  2. To develop bioinformatics tools to detect higher order genomic interactions that will permit whole-genome association studies.


Participants

Position

Emelia J. Benjamin Principal Investigator
Eric Lander Co- Principal Investigator
Joel Hirschhorn Principal Investigator
Daniel Levy Co-Investigator
Martin G. Larson Co-Investigator
Christopher O'Donnell Co- Principal Investigator
Ramachandran S. Vasan Co-Investigator
Stacey Gabriel Research Associate
Christopher Newton-Cheh Research Associate
Sekar Kathiresan Research Associate
Jared Drake Bioinformatician
Stacy Musone Research Technician
Amy Camargo Research Technician

Project Publications

Framingham Heart Study

Genetic linkage for left ventricular mass phenotypes in the Framingham Heart Study.
Transformation of left ventricular (LV) phenotypes in a genome scan in the NHLBI’s Framingham Heart Study (FHS).
QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study
CCL2 Polymorphisms are Associated with Serum MCP-1 Levels and Myocardial Infarction in the Framingham Heart Study.
Common Genetic Variation at the Endothelial Nitric Oxide Synthase Locus and Relations to Brachial Artery Vasodilator Function in the Community
Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
The PR interval is a heritable quantitative trait with evidence for linkage to chromosome 4 in a genome-wide scan: the Framingham Heart Study.
Association of genetic variants in KCNH2 with QT interval duration in the Framingham Heart Study.


Affiliated Institutions  | Sponsored by the National Heart, Lung, and Blood Institute
Copyright 2001-2003, CardioGenomics   | Designed by Digizyme